Estée Lauder's Old High Is the Wrong Benchmark for Its Recovery

Estée Lauder shares trade at less than one-third of their January 2022 peak, but the distance to that old price is not a measure of value. A recovery of roughly 247% would be required to revisit the former high, and that outcome depends on future earnings rather than the stock's history.

The company's fiscal 2026 results show genuine improvement. Net sales rose 5% to $15.049 billion and organic sales increased 3%. Gross margin expanded to 75.5% from 74.0%, while management reported a 320-basis-point improvement in adjusted operating margin. Those gains suggest the profit-recovery program is producing operating benefits.

The recovery is not complete. Estée Lauder still needs sustained volume growth across regions and brands, not only pricing, currency effects or cost reductions. Beauty demand in China, travel retail performance and the balance between consumer marketing and overhead savings remain important.

The former peak was set under different growth expectations and market multiples. Investors should therefore test a range of revenue growth and operating margins instead of assuming the old valuation will return automatically.

The next catalyst is the fiscal 2027 first-quarter report scheduled for November 2, 2026. Evidence that organic growth and margin expansion are continuing would strengthen the recovery case. A slowdown would show why anchoring to the 2022 share price is risky. The business is improving, but the old high is an outcome to earn, not a default destination.